Relationship between bone biochemical markers versus glucose/lipid metabolism and atherosclerosis; a longitudinal study in type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 92, Issue 3, 2011, Pages 393-399

  Kanazawa, Ippei ^a   Yamaguchi, Toru ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Lipids; Metabolism; Osteocalcin; Type 2 diabetes mellitus

Indexed keywords

4 THIAZOLIDINONE DERIVATIVE; ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BIOCHEMICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; OSTEOCALCIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; JAPANESE; LIPID METABOLISM; LONGITUDINAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ATHEROSCLEROSIS; BLOOD GLUCOSE; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; HUMANS; LIPID METABOLISM; LONGITUDINAL STUDIES; OSTEOCALCIN; TUNICA INTIMA; TUNICA MEDIA;

EID: 79957998376     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.03.015     Document Type: Article

References (35)

1. Browner W.S., Pressman A.R., Nevitt M.C., Cummings S.R. Mortality following fractures in older women. Arch Intern Med 1996, 156:1521-1525.
2. Cooper C., Atkinson E.J., Jakobsen S.J., O'Fallon W.M., Melton L.J. Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993, 137:1001-1005.
3. Browner W.S., Seeley D.G., Vogt T.M., Cummings S.R. Non-trauma mortality in elderly women with low bone mineral density. Lancet 1991, 338:355-358.
4. von der Recke P., Hansen M.A., Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999, 106:273-278.
5. Watson K.E., Bostrom K., Ravindranath R., Lam T., Norton B., Demer L.L. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994, 93:2106-2113.
6. Dhore C.R., Cleutjens J.P., Lutgens E., Cleutjens K.B., Geusens P.P., Kitslaar P.J., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001, 21:1998-2003.
7. Ensrud K.E., Lipschutz R.C., Cauley J.A., Seeley D., Nevitt M.C., Scott J., et al. Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Am J Med 1997, 103:274-280.
8. Johnell O., O'Neill T., Felsenberg D., Kanis J., Cooper C., Silman A.J. Anthropometric measurements and vertebral deformities. European Vertebral Osteoporosis Study (EVOS) Group. Am J Epidemiol 1997, 146:287-293.
9. Cappuccio F.P., Meilahn E., Zmuda J.M., Cauley J.A. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporosis Fractures Research Group. Lancet 1999, 354:971-975.
10. Yamaguchi T., Sugimoto T., Yano S., Yamauchi M., Sowa H., Chen Q., et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr J 2002, 49:211-217.
11. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 2007, 18:427-444.
12. Nickola T.L., Leonard M.B., Shane E. Chronic kidney disease and bone fracture: a growing concern. Kidney Int 2008, 74:721-731.
13. Benson B.W., Shulman J.D. Inclusion of tobacco exposure as a predictive factor for decreased bone mineral content. Nicotine Tob Res 2005, 7:719-724.
14. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038.
15. Fujishima M., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama study. Diabetes 1996, 45:S14-16.
16. Verhaeghe J., Suiker A.M., Nyomba B.L., Visser W.J., Einhorn T.A., Dequeker J., et al. Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 1989, 124:573-582.
17. Gerdhem P., Isaksson A., Akesson K., Obrant K.J. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporosis Int 2005, 16:1506-1512.
18. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., Sugimoto T. Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94:3031-3037.
19. Okazaki R., Totsuka Y., Hamano K., Ajima M., Miura M., Hirota Y., et al. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 1997, 82:2915-2920.
20. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
21. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008, 105:5266-5270.
22. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Kurioka S., Yano S., et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94:45-49.
23. Kindblom J.M., Ohlsson C., Ljunggren O., Karlsson M.K., Tivesten A., Smith U., et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009, 24:785-791.
24. Fernandez-Real J.M., Izquierdo M., Ortega F., Gorostiaga E., Gomez-Ambrosi J., Moreno-Navarrete J.M., et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009, 94:237-245.
25. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., Sugimoto T. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 2009, 160:265-273.
26. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., Sugimoto T. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcified Tissue Int. 2008, 83:324-331.
27. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Kurioka S., Yano S., et al. Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus. Endocr J 2008, 55:667-675.
28. Pennisi P., Signorelli S.S., Riccobene S., Celotta G., Di Pino L., La Malfa T., et al. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 2004, 15:389-395.
29. Gerdhem P., Isaksson A., Akesson K., Obrant K.J. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 2005, 16:1506-1512.
30. Zhou M., Ma X., Li H., Pan X., Tang J., Gao Y., et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 2009, 161:723-729.
31. Brownbill R.A., Ilich J.Z. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women. J Womens Health (Larchmt) 2006, 15:261-270.
32. Law M.R., Hackshaw A.K. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997, 315:841-846.
33. Blumsohn A., Naylor K.E., Timm W., Eagleton A.C., Hannon R.A., Eastell R. Absence of marked seasonal change in bone turnover: a longitudinal and multicenter cross-sectional study. J Bone Miner Res 2003, 18:1274-1281.
34. Kanazawa I., Yamaguchi T., Tada Y., Yamauchi M., Yano S., Sugimoto T. Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone 2011, 48:270-275.
35. Duncan E., Ezzat V., Kearney M. Insulin and endothelial function: physiological environment ddefines effect on atherosclerotic risk. Curr Diabetes Rev 2006, 2:51-61.